Financial Ratios

SHARMA EAST INDIA HOSPITALS & MEDICAL RESEARCH LTD.

NSE : NABSE : 524548ISIN CODE : INE465H01012Industry : Hospital & Healthcare ServicesHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)2.542.071.940.930.81
   CEPS(Rs)6.774.453.912.242.40
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)29.5326.5624.4522.5021.37
   Tax Rate(%)-5.2018.2723.8218.8622.68
Margin Ratios
   Core EBITDA Margin(%)15.9213.24-8.0811.924.33
   EBIT Margin(%)9.529.0118.829.478.31
   Pre Tax Margin(%)3.834.8810.292.332.33
   PAT Margin (%)4.023.997.841.891.81
   Cash Profit Margin (%)10.738.5715.774.545.34
Performance Ratios
   ROA(%)3.903.593.291.461.38
   ROE(%)9.068.128.274.253.87
   ROCE(%)12.0310.6410.018.887.70
   Asset Turnover(x)0.970.900.420.770.77
   Sales/Fixed Asset(x)1.691.811.092.472.12
   Working Capital/Sales(x)38.098.742.477.416.95
Efficiency Ratios
   Fixed Capital/Sales(x)0.590.550.920.400.47
   Receivable days67.5865.00166.7492.5683.02
   Inventory Days8.6110.9426.4613.9415.63
   Payable days296.73257.23525.58238.803538.84
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)0.530.430.870.650.61
   EV/Core EBITDA(x)3.243.183.255.405.17
   EV/EBIT(x)5.524.804.616.917.38
   EV/CE(x)0.580.530.470.670.48
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)21.64109.56-49.719.76-7.95
   Core EBITDA Growth(%)45.356.3911.0212.3113.89
   EBIT Growth(%)28.650.27-0.0425.1234.05
   PAT Growth(%)22.636.74108.2715.06101.59
   EPS Growth(%)22.636.74108.2715.07101.58
Financial Stability Ratios
   Total Debt/Equity(x)0.790.450.670.901.38
   Current Ratio(x)1.051.251.411.231.16
   Quick Ratio(x)1.001.191.341.171.12
   Interest Cover(x)1.672.192.211.331.39
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.